The role of BRCA and PARP in DNA repair and BRCA-related breast cancer - European Medical Journal

The role of BRCA and PARP in DNA repair and BRCA-related breast cancer

Oncology

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof. Dr. med. Peter Fasching (Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany) describes targeting the defect in DNA repair in BRCA-related breast cancer with poly (ADP-ribose) polymerase (PARP) inhibitors.

In BRCA-related breast cancer cells, DNA double-strand break repair is impaired, so inhibition of PARP, which has a role in DNA single-strand break repair, increases the susceptibility for additional DNA damage and cell death. Accordingly, PARP inhibitors may be important novel therapeutic agents for the treatment of BRCA-related breast cancer.

This programme is supported by BioMarin Pharmaceutical.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now